A Message from David N. Louis, MD, Pathologist-in-Chief at Massachusetts General Hospital

Welcome to the MGH Pathology website where you'll find up-to-date information on the Pathology Department's training and educational programs, research opportunities and clinical activities, as well as contact information about the pathology staff.

The goal of the MGH Pathology Service is excellence in service to patients, present and future. For present patients, our goal is accurate diagnosis, communicated effectively and efficiently. For future patients, we promote research in the diagnosis and pathogenesis of disease and train leaders in pathology.

These goals are captured in our mission statement:

To deliver the highest quality pathology services and to move the field of pathology forward.

Our department is completely subspecialized, so that each organ system has its dedicated pathology team of specialists, in many cases combining clinical and research interests. We are structured this way to optimize clinical expertise, teaching and research productivity over a large department and within a dynamic set of institutions. Indeed, the department is large, with nearly 100 faculty, 800 employees and approximately 50 residents and clinical fellows; a budget of over $125 million per year; and test volumes that exceed 10 million clinical laboratory tests, 80,000 surgical specimens, 60,000 cytopathology specimens and 35,000 red cell transfusions each year.

David N. Louis, MDPathology has entered an era of exhilarating growth. MGH Pathology is committed to being part of this revolution in personalized medical care that will lead to earlier diagnosis, more precise prognosis and tailored therapy. Indeed, over the past five years, the department has developed many new initiatives to move the department and field forward. For example, we have:

  • Restructured the department in a mission-driven manner, administratively unifying the diverse laboratories so that the emphasis is on unified, interdisciplinary clinical services, teaching and research.
  • Added a Pathology Informatics division that includes a highly successful fellowship program and a considerable research portfolio that includes numerous collaborations with international, high-tech companies.
  • Developed the Center for Integrated Diagnostics, a hospital-wide initiative based in Pathology that will provide an integrated platform to drive innovation in molecular diagnostics through close interactions with other departments and diagnostic laboratories, through technology development and adoption, and through translational research in novel diagnostics.
  • Re-invigorated the research program, with tremendous growth recognized by increases in research faculty, grant funding, research space and Harvard graduate students; by appointments to the Howard Hughes Medical Institute and to the Broad Institute of Harvard and MIT; and by scientific publications and national recognition such as advanced cancer molecular diagnostic breakthroughs.
  • Restructured and expanded the residency and fellowship programs to customize and facilitate careers in academic pathology.
  • Invested in many clinical areas of the department, notably in recruitment of new clinical faculty and in molecular diagnostics, and with completed plans for major infrastructure updates across the clinical laboratories.

These initiatives build on the remarkable strengths and traditions that have long made MGH Pathology a leader in the field, allowing the department to continue its role of advancing diagnosis and discovery.


Updated 11/26/2013